No name

Did you know that schizophrenia affects more than 1 percent of the world's population?

See NARSAD Grants at work on the latest schizophrenia research

Schizophrenia is a severe, chronic, and generally disabling brain and behavior disorder. It is most accurately described as a psychosis - a type of illness that causes severe mental disturbances that disrupt normal thoughts, speech, and behavior. Schizophrenia is believed to be caused by a combination of genetic and environmental factors.

Positive symptoms may include delusions, thought disorders, and hallucinations. People with schizophrenia may hear voices other people don't hear, or believe other people are reading their minds, controlling their thoughts, or plotting to harm them. Negative symptoms may include avolition (a lack of desire or motivation to accomplish goals), lack of desire to form social relationships, and blunted affect and emotion. Cognitive symptoms involve problems with attention and memory, especially in planning and organization to achieve a goal. Cognitive deficits are the most disabling for patients trying to lead a normal life.

learn more about schizophrenia

Visit the Schizophrenia Research Forum, fully sponsored by the Brain & Behavior Research Foundation—a virtual community of scientists collaborating in their quest for causes, improved treatments, and better understanding of schizophrenia.

Visit the Schizophrenia Research Forum for more information about research

 

Jonathan Javitch, M.D., Ph.D., of Columbia University
Jonathan Javitch, M.D., Ph.D.
February 01, 2011
From The Quarterly, Winter 2011 NARSAD Scientific Council member Jonathan Javitch, M.D., Ph.D., of Columbia University, is part of a team that recently...
John H. Krystal, M.D., Chair, Department of Psychiatry, Yale University
John H. Krystal, M.D.
February 01, 2011
From The Quarterly, Winter 2011 “I think we have arrived at a tipping point in the maturation of psychiatry,” says John H. Krystal, M.D., NARSAD Scientific...
Bryan L. Roth, M.D., Ph.D
Bryan L. Roth, M.D., Ph.D
February 01, 2011
Bryan L. Roth, M.D., Ph.D., NARSAD Scientific Council member, is a well known expert on psychopharmacology. In recent years, he has developed several...
John H. Krystal, M.D., Chair, Department of Psychiatry, Yale University
John H. Krystal, M.D.
February 01, 2011
As a member of the NARSAD Scientific Council, Dr. John H. Krystal knows the organization intimately. But he first came to know it in the way that thousands of...
David E. Kemp, M.D., Assistant Professor of Psychiatry and Director, Mood and Metabolic Clinic, Case Western Reserve University
David E. Kemp, M.D.
February 01, 2011
From The Quarterly, Winter 2011 Mental illness is a major risk factor for cardiovascular disease and early death. People with depression and diabetes...

Pages

Subscribe to